NSABP FOUNDATION, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 16109
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0051,348 PREDICTION OF LIKELIHOOD OF CANCER RECURRENCEAug 11, 17Feb 22, 18[C12Q]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8868352 Predicting response to chemotherapy using gene expression markersMar 16, 11Oct 21, 14[C12Q, G06F]
8632980 Gene expression markers for prediction of patient response to chemotherapyOct 21, 11Jan 21, 14[C12Q]
8367345 Gene expression markers for colorectal cancer prognosisMar 06, 12Feb 05, 13[C12Q]
8273537 Gene expression markers for colorectal cancer prognosisOct 25, 10Sep 25, 12[C12Q]
8198024 Gene expression markers for colorectal cancer prognosisJan 19, 11Jun 12, 12[C12Q]
8153378 Gene expression markers for colorectal cancer prognosisJan 29, 10Apr 10, 12[C12Q]
8153379 Gene expression markers for colorectal cancer prognosisOct 25, 10Apr 10, 12[C12Q]
8153380 Gene expression markers for colorectal cancer prognosisOct 25, 10Apr 10, 12[C12Q]
8067178 Gene expression markers for prediction of patient response to chemotherapyMar 13, 09Nov 29, 11[C12Q, G01N]
8029995 Gene expression markers for colorectal cancer prognosisOct 25, 10Oct 04, 11[C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0348,821 Defective Mismatch Repair and Benefit from Bevacizumab for Colon CancerAbandonedMay 23, 14Nov 27, 14[A61K, C12Q, G01N, C07K]
2014/0206,545 GENE EXPRESSION MARKERS FOR PREDICTION OF PATIENT RESPONSE TO CHEMOTHERAPYAbandonedDec 18, 13Jul 24, 14[C12Q]
2013/0251,710 Methods to Expand the Eligible Patient Population for HER2-Directed Targeted TherapiesAbandonedMay 08, 13Sep 26, 13[A61K, C12Q]
2013/0102,492 GENE EXPRESSION MARKERS FOR COLORECTAL CANCER PROGNOSISAbandonedDec 28, 12Apr 25, 13[C12Q]
2011/0262,434 Methods to Expand the Eligible Patient Population for HER2-Directed Targeted TherapiesAbandonedApr 25, 11Oct 27, 11[A61K, C12Q, A61P]
2010/0266,589 ADJUVANT CANCER THERAPYAbandonedApr 20, 10Oct 21, 10[A61K, A61P]
2010/0267,032 Prediction of Likelihood of Cancer RecurrenceAbandonedFeb 17, 10Oct 21, 10[C12Q, C40B]
2010/0184,041 Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment ResponseAbandonedOct 09, 09Jul 22, 10[C12Q]
2009/0304,697 Identification and use of prognostic and predictive markers in cancer treatmentAbandonedJun 02, 09Dec 10, 09[A61K, C12Q]
2009/0258,795 Gene expression markers for prediction of patient response to chemotherapyAbandonedMar 14, 08Oct 15, 09[C12Q, C40B]
2009/0035,311 Identification and use of prognostic and predictive markers in cancer treatmentAbandonedSep 22, 08Feb 05, 09[A61K, C12Q, G01N, A61P, C40B]
2007/0254,305 Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissueAbandonedApr 30, 07Nov 01, 07[C12Q]
2006/0127,935 Identification and use of prognostic and predictive markers in cancer treatmentAbandonedDec 15, 05Jun 15, 06[C12Q, G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.